摘要
通过回顾近年来中药注射剂不良反应的相关文献,主要从药物自身因素、生产过程中存在的问题、临床应用中的问题等方面分析中药注射剂临床不良反应事件发生的原因,提出严格规范药品质量的监控,建立统一的质量标准;坚持辨证用药,注意药物的配伍;控制用药剂型及剂量等方面减少中药注射剂不良反应。
Through the review on the adverse drug reaction （ADR） relevant reports of Chinese materia medica injection （CMMI） in recent years, we found that the major factors led to the ADR are as follows： the herbs or medicines of themselves, the problems appeared during the production process, and the factors appeared in clinical application. Therefore, we put forward the following suggestions： Establishing a unified standard for the medicine quality and strengthen the monitoring of it; Insisting on the utilization of different medicines according to various syndrome, paying attention to the compatibility of the drugs during the clinical application, and choosing the proper dosage of the drug and dosage form. Various links should be standardized in clinical application of CMMI so as to achieve the aim of clinical treatment.
出处
《药物评价研究》
CAS
2012年第3期216-219,共4页
Drug Evaluation Research
基金
教育部"长江学者和创新团队发展计划"资助(IRT0871)
中央高校基本科研业务费专项资金(1112KYQN43)
关键词
中药注射剂
不良反应
对策
Chinese materia medica injection （CMMI）
adverse drug reaction （ADR）
countermeasures
